INSIGHTS ON QUALITY ASSURANCE

• Looking Back At USP <86>: Key Changes And Their Impact On Biological Reactivity Testing

  USP <86> introduces validated recombinant alternatives for endotoxin testing, supporting animal-free QC. Learn key validation, comparability, and regulatory considerations.

• Continuous Readiness Is Becoming The New Operating Standard In MedTech

  Transitioning from episodic audit preparation to continuous readiness stabilizes submission timelines and aligns compliance dynamically with product development.

• Turn Regulatory Readiness Into An Operational Advantage

  Paper-based GxP workflows hide risk and stall progress. Learn how embedding compliance into digital execution creates real-time traceability and turns regulatory readiness into an advantage.

• Why Composable Manufacturing Execution Is Becoming The New Standard

  Low-code MES promises speed, but agility comes from ownership. Composable, no-code approaches give operations teams the ability to change workflows themselves and respond faster to disruption.

• Multi-Lane Checkweigher Overview

  6/16/2026

  Optimize high-speed lines with compact multi-lane checkweighing that monitors twelve channels on one screen, features detachable conveyors, and prevents product jams.

• Automating Cell Therapy Manufacturing Without Redesigning Workflows

  6/23/2026

  Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.

• The Clear Solution: Navigating Contamination Control For Ophthalmic Injectables

  8/12/2026

  As the intravitreal therapy market grows and applicable regulations evolve, continued compliance demands technological savvy and rigorous contamination control.

• Effective Contamination Control

  6/16/2025

  Discover key strategies for contamination control in cleanrooms, as well as explore contaminant sources, behaviors, and best practices for cleaning and removal to ensure high standards of product and process quality.

• A Clear Path To Rapid, Consistent Biosimilar Development

  6/23/2026

  Faster timelines don’t have to come at the expense of quality or consistency. Discover proven strategies to generate stable, high-performing cell lines while reducing risk and supporting reliable scale-up.